Laquinimod is a quinoline-based immunomodulatory agent primarily investigated for the treatment of multiple sclerosis and other autoimmune conditions due to its neuroprotective and anti-inflammatory properties.… Read more






Laquinimod is a quinoline-based immunomodulatory agent primarily investigated for the treatment of multiple sclerosis and other autoimmune conditions due to its neuroprotective and anti-inflammatory properties. This category provides essential pharmaceutical reference standards required for the rigorous analysis of the drug substance. Laboratory professionals rely on these high-purity compounds for critical processes such as impurity profiling, the validation of analytical methods, and routine quality control. The collection includes chemically synthesized impurities, such as the desethyl variant, as well as stable isotope labelled compounds like Laquinimod-d5. These labelled internal standards are indispensable for accurate quantification during mass spectrometry analysis. By utilizing these precise reference materials, researchers ensure compliance with regulatory standards and maintain the highest levels of accuracy when monitoring the synthesis and stability of Laquinimod and its related derivatives in complex pharmaceutical matrices.